Diabetes Mellitus and Stroke: Pathophysiological Connections and Therapeutic Potential of GLP-1 and GLP-1/GIP Receptor Agonists

Both diabetes mellitus (DM) and stroke are major global health challenges with high morbidity and mortality. DM is a major risk factor for stroke, contributing to both increased incidence and worse clinical outcomes. Incretin-based therapies, including glucagon-like peptide-1 receptor agonists (GLP-...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Maria-Alexandra Paceana, Liliana Mititelu Tartau, Ianis Kevyn Stefan Boboc, Carmen Nicoleta Oancea, Anca Berbecaru-Iovan, Cezar Ilie Foia, Cosmin Gabriel Tartau, Maria Bogdan
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	MDPI AG 2026-05-01
Ráidu:	Pharmaceutics
Fáttát:	diabetes mellitus stroke antidiabetic drugs GLP-1 receptor agonists GLP-1/GIP receptor agonists
Liŋkkat:	https://www.mdpi.com/1999-4923/18/5/620
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!